The growth inhibition of human lymphoblastoid cells by human interferon preparations (HIF) and a mock-interferon preparation (Mock-IF) was studied. HIF was induced in suspensions of primary human leukocytes by Newcastle Disease Virus. Mock-IF was prepared from uninduced cell suspension of a comparable batch. The highest degree of inhibition of cell propagation was ob tained on the EBV producer line P3HR1, the inhibition of the cell lines Raji and SKL 1 was significantly lower, no effect was observed on the cell line RPMI 1788 originating from a healthy donor. Mock-IF also caused a growth inhibition but to a lower degree as HIF. HIF and Mock-IF are similar in the following properties: 1. Stability at pH 2 at 4 °C for four days, 2. sensitivity to tryptic digestion, and 3. molecular weights in the range between 5,000 and 40,000 daltons.
I.
Gresser et al. have described experiments showing that mouse interferon preparations, in ad dition to the antiviral effect, had an inhibitory acti vity on the m ultiplication of mouse cells in vitro 2. A similar effect was observed by K. Cantell 3 who found an inhibition of propagation of human lym phoblastoid cells in cultures which had been incu bated with human interferon for at least several weeks. E. V. Gaffney et al. have reported growth inhibition of SV 40 transform ed hum an amniotic cells by human interferon, while there was no ef fect on established hum an cell lines as HeLa or F L 4.
We studied the in vitro anticellular activity of human leukocyte interferon preparations on dif ferent lymphoblastoid cell lines from normal or tum or patients. In addition, we wanted to elucidate whether the antiviral and anticellular activity of our different interferon preparations were proper ties of the same substance. We used four different lymphoblastoid cell lines. One of these was estab lished by G. E. Moore from a healthy donor Burkitt 1 7 8 8 )5,6; two others mere isolated from Burkitt lymphoma patients (R a ji8, P 3 H R 1 ); and the fourth was obtained from a patient with mono cytic leukemia (SK L 1) 7. Both Burkitt lymphoma cell lines contain Epstein Barr Virus (EBV) genom e10, but only the P3HR1 is an EBV pro ducer cell 9.
Materials and Methods

Interferon
The induction of interferon was performed ac cording to the method of H. Strander and K. Can tell 11 with Newcastle Disease Virus (NDV) strain Beaudette, which was propagated in embryonated chicken eggs and purified by twofold sedimentation in the ultracentrifuge. W ashed hum an peripheral leukocytes (7 -9xl06 cells/ml) were incubated with a multiplicity of 10 virus particles per cell at 37 °C for 13 hours in Eagle's Medium MEM supplemented with inactivated human serum (2%). After incubation, the cells were removed by low speed centrifugation, the supernatant adjusted to pH 2 and incubated for virus inactivation at 4 °C for four days. Thereafter the solution was chromato graphed on Sephadex G75 (Pharm acia, Frank furt, Germany) and eluted with 0.2 M Glycin/HClbuffer pH 3.5. The fractions following the albumin were pooled, concentrated by ultrafiltration, steril ized by filtration and stored at -20 °C. The buffer of the pooled fractions was changed to 0.15 M NaCl by chromatography on Sephadex G25. One pre paration (H IF2) was rechrom atographed before the buffer was changed. Before the last concentra tion step by ultrafiltration, \% Haemaccel, modified gelatine (Behringwerke AG, M arburg, G erm any), was added to stabilize the interferon activity. This component was disregarded in the calculation of the specific antiviral activity ( = antiviral activity per mg protein, see Table I ) .
Mock interferon
This preparation was obtained by the same proce dure as interferon (H IF 3, Table I ) using un induced leukocyte suspensions as starting material. We have defined the supernatant of 4 x 103 leuko cytes after chromatography on Sephadex G75 and G25 and concentration by ultrafiltration a formal unit of our mock interferon preparation. This amount is equal to the supernatant from the same number of induced leukocytes, which had the anti viral activity of one unit of the British Research Standard A 69/19 12.
Interferon assay
The determination of the antiviral activity of interferon was done as described by H. Strander and K. C antell11 in a plaque reduction assay. Our challenge virus was Semliki Forest Virus (SFV ). Interferon was tested in serial twofold dilutions, each of which was given to three cell cultures. The titers were calculated according to the units of the British Research Standard Hum an Interferon A 69/19.
Inhibition of cell growth by interferon and mock interferon
The lymphoblastoid cell line RPM I 1788 (p u r chased from Associated Biomedic Systems, Buffalo, N. Y., USA) and the cell lines Raji, P3HR1 and SKL 1 (obtained from Prof. zur Hausen, Institut für Klinische Virologie, Erlangen, Germany) were propagated in medium RPMI 1640 supplemented with 10% fetal calf serum, 2 0 0 //g/m l streptomycin, 2 0 0 //g/m l neomycin and 200 units/ml penicillin in a cell roller apparatus (Bellco Glass Inc., Vine land, N. J., U SA ). The final cell suspension of a concentration of 1.5 -2.5 x 106 cell/ml was diluted by the addition of interferon or mode interferon in complete medium RPM I 1640 to a cell concentra tion of 2 x 105 cells/ml. These suspensions were in cubated in Erlenmeyer flasks without agitation (a 200 ml flask was filled with 40 ml cell suspension) at 37 °C. Control cell suspensions contained the buffer solution used for the interferon preparations in the corresponding dilution. The cell growth was followed by cell counting and by [2-14C] 
in 50 ju\. Two different lots with the specific activities of 6mCi/mM (Fig. 1) , and 60mCi/mM (Fig. 3) were used. The samples were incubated at 37 °C in a humidified atmo sphere with 8 % C 0 2 . The cells were then preci pitated on glass fiber filters (Sartorius GmbH, Göttingen, G erm any), and washed three times with excess distilled water. After drying the filters, they were immersed in a toluene scintillator, and the incorporated radioactivity was measured in a liquid scintillation spectrometer. Each point represents the average values of six samples. Viability tests were perform ed in a haemocytometer with the trypan blue exclusion test.
R esults
The growth of the three cell lines P3H R 1, Raji, and SKL 1 was reduced after the addition of 1000 and 4000 IF-units/ml (Fig. 1) . The growth inhi bition of the EBV producing cell line P3HR1 was considerably higher than that of the other two cell lines. Cell growth in relation to interferon con centration was studied by cell counting after a five day incubation period. The results for the cell lines P3HR1, Raji, and RPMI 1788 are given in Fig. 2 . The data presented in Fig 1 and 2 were obtained with three different human interferon preparations (Table I) . The cell line P3HR1 shows a similar sensitivity to the three preparations. As can be seen in Fig. 2 , P3HR1 was most sensitive, while Raji was less sensitive to the anticellular activity. No growth inhibition was observed in the case of RPMI 1788.
We used mock interferon to investigate whether only preparations with a high antiviral activity in hibit cell proliferation. For comparison of the pro perties of our interferon and mock interferon pre parations see Table I . Our assumption that anticellular activity is only linked to interferon, is contradicted by the data given in Fig. 3 . The three interferon sensitive cell lines showed growth in hibition also by mock interferon. This effect is weak in the case of Raji and SKL 1, but of almost the same magnitude as the interferon effect on P3HR1.
D iscussion
Three interferon preparations caused an inhibi tion of cell proliferation in three lymphoblastoid cell lines originally isolated from tumor patients. The greatest effect was obtained on P3HR1, whereas the sentivities of Raji and SKL 1 were significantly lower. No influence could be observed on the cell line RPMI 1788 originally isolated from a healthy donor. The num ber of the studied lymphoblastoid cell lines is too small to permit any interpretation of the differences between the cell lines. Surprisingly, mock interferon had an inhibiting effect on the proliferation of the three interferon sensitive cell lines, which was comparable to the activity of the interferon preparations in the case of P3HR1. J. A. Green et al. 13>14 reported on a factor with sim ilar properties which inhibited the pro liferation of established human cell lines such as HeLa. The antiviral activity, however, had not been tested. This factor was isolated from the super natants of both phytohemagglutinin-stimulated and non-stimulated prim ary human leukocytes. By contrast I. G resser15 found that mock interferon preparations did not inhibit cell proliferation. He therefore concluded that the antiviral and anticellular activities of mouse interferon preparations are likely to be properties of the same molecule, namely interferon. However, Gresser's and our re sults cannot be directly compared since his inter feron preparation was of murine origin and had been synthesized by cells of different organs.
In our opinion, two possible explanations could be given concerning the antiviral activity of the interferon and mock interferon preparations:
1. Leukocytes incubated in vitro at 37 °C syn thesize an anticellular substance, which is pro duced in increasing amounts during interferon induction. This substance could be one of the cell growth inhibitors called chalones 16. In this case, the anticellular substance would have no antiviral property, and the interferon would be without anticellular activity. The anticellular substance in the mock inter feron preparation is the same as postulated above. However, under the conditions of inter feron induction, another substance with anticellular activity would be induced, which could be identical with interferon. Therefore two sub stances with cell growth inhibitory properties would exist in the interferon preparation, one of which could display antiviral and anticellular activity.
The physico-chemical similarities of the anticellular substance and interferon are based on the fol lowing comparisons. Both are stable at pH 2 at 4 °C for four days. They are sensitive to tryptic digestion. They have a molecular weight in the range between 5,000 and 40,000 daltons. We are indebted to Professor H. zur Hausen (In stitut für Klinische Virologie, Erlangen, Germany) for supplying cell lines, and for valuable advice regarding cultivation of the cells in vitro. The tech nical assistance of H. Damm is greatly appreciated.
